Skip to main content
Log in

Is Fecal Diversion Needed in Pelvic Anastomoses During Hyperthermic Intraperitoneal Chemotherapy (HIPEC)?

  • Colorectal Cancer
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

An Erratum to this article was published on 25 May 2017

Abstract

Background

The role of fecal diversion with pelvic anastomosis during cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is not well defined.

Methods

A retrospective review of patients who underwent CRS and HIPEC between 2009 and 2016 was performed to identify those with a pelvic anastomosis (colorectal, ileorectal, or coloanal anastomosis).

Results

The study identified 73 patients who underwent CRS and HIPEC at three different institutions between July 2009 and June of 2016. Of these patients, 32 (44%) underwent a primary anastomosis with a diverting ileostomy, whereas 41 (56%) underwent a primary anastomosis without fecal diversion. The anastomotic leak rate for the no-diversion group was 22% compared with 0% for the group with a diverting ileostomy (p < 0.01). The 90-day mortality rate for the no-diversion group was 7.1%. The hospital stay was 14.1 ± 8.0 days in the diversion group compared with 17.9 ± 12.5 days in the no-diversion group (p = 0.12). Of those patients with a diverting ileostomy, 68% (n = 22) had their bowel continuity restored, 18% of which required a laparotomy for reversal. Postoperative complications occurred for 50% of those who required a laparotomy and for 44% of those who did not require a laparotomy (p = 0.84).

Conclusion

Diverting ileostomies in patients with a pelvic anastomosis undergoing CRS and HIPEC are associated with a significantly reduced anastomotic leak rate. Reversal of the diverting ileostomy in this patient population required a laparotomy in 18% of the cases and had an associated morbidity rate of 50%.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Paun BC, Cassie S, Maclean AR, Dixon E, Buie WD. Postoperative complications following surgery for rectal cancer. Ann Surg. 2010;251:807–18. doi:10.1097/SLA.0b013e3181dae4ed.

    Article  PubMed  Google Scholar 

  2. Vignali A, Fazio VW, Lavery IC, et al. Factors associated with the occurrence of leaks in stapled rectal anastomoses: a review of 1014 patients. ACS. 1997;185:105–13. doi:10.1016/S1072-7515(97)00018-5.

    CAS  Google Scholar 

  3. Akiyoshi T, Ueno M, Fukunaga Y, et al. Incidence of and risk factors for anastomotic leakage after laparoscopic anterior resection with intracorporeal rectal transection and double-stapling technique anastomosis for rectal cancer. Am J Surg. 2011;202:259–64. doi:10.1016/j.amjsurg.2010.11.014.

    Article  PubMed  Google Scholar 

  4. Laparoscopic Colorectal Surgery Study Group (LCSSG), Köckerling F, Rose J, et al. Laparoscopic colorectal anastomosis: risk of postoperative leakage. Surg Endosc. 2014;13:639–44. doi:10.1007/s004649901064.

    Google Scholar 

  5. Karanjia ND, Corder AP, Bearn P, Heald RJ. Leakage from stapled low anastomosis after total mesorectal excision for carcinoma of the rectum. Br J Surg. 1994;81:1224–6. doi:10.1002/bjs.1800810850.

    Article  CAS  PubMed  Google Scholar 

  6. Trencheva K, Morrissey KP, Wells M, et al. Identifying important predictors for anastomotic leak after colon and rectal resection. Ann Surg. 2013;257:108–13. doi:10.1097/SLA.0b013e318262a6cd.

    Article  PubMed  Google Scholar 

  7. Jung SH, Yu CS, Choi PW, et al. Risk factors and oncologic impact of anastomotic leakage after rectal cancer surgery. Dis Colon Rectum. 2008;51:902–8. doi:10.1007/s10350-008-9272-x.

    Article  PubMed  Google Scholar 

  8. Rullier E, Laurent C, Garrelon JL, Michel P, Saric J, Parneix M. Risk factors for anastomotic leakage after resection of rectal cancer. Br J Surg. 1998;85:355–8. doi:10.1046/j.1365-2168.1998.00615.x.

    Article  CAS  PubMed  Google Scholar 

  9. Mäkelä JT, Kiviniemi H, Laitinen S. Risk factors for anastomotic leakage after left-sided colorectal resection with rectal anastomosis. Dis Colon Rectum. 2003;46:653–60. doi:10.1007/s10350-004-6627-9.

    Article  PubMed  Google Scholar 

  10. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:10. doi:10.1056/NEJMoa040694.

    Article  Google Scholar 

  11. Kapiteijn E, Marijnen CAM, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345:638–46. doi:10.1056/NEJMoa010580.

    Article  CAS  PubMed  Google Scholar 

  12. Mealy K, Burke P, Hyland J. Anterior resection without a defunctioning colostomy: questions of safety. Br J Surg. 1992;79:305–7. doi:10.1002/bjs.1800790406.

    Article  CAS  PubMed  Google Scholar 

  13. Younan R, Kusamura S, Baratti D, et al. Bowel complications in 203 cases of peritoneal surface malignancies treated with peritonectomy and closed-technique intraperitoneal hyperthermic perfusion. Ann Surg Oncol. 2005;12:910–18. doi:10.1245/ASO.2005.11.030.

    Article  PubMed  Google Scholar 

  14. Jacquet P, Stephens AD, Averbach AM, et al. Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy. Cancer. 1996;77:2622–9. doi:10.1002/(SICI)1097-0142(19960615)77:12<2622::AID-CNCR28>3.0.CO;2-T.

    Article  CAS  PubMed  Google Scholar 

  15. Chua TC, Yan TD, Saxena A, Morris DL. Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure? Ann Surg. 2009;249:900–7. doi:10.1097/SLA.0b013e3181a45d86.

    Article  PubMed  Google Scholar 

  16. de Cuba EMV, Verwaal VJ, de Hingh IHJT, et al. Morbidity associated with colostomy reversal after cytoreductive surgery and HIPEC. Ann Surg Oncol. 2013;21:883–90. doi:10.1245/s10434-013-3370-2.

    Article  PubMed  Google Scholar 

  17. Wong NY, Eu KW. A defunctioning ileostomy does not prevent clinical anastomotic leak after a low anterior resection: a prospective, comparative study. Dis Colon Rectum. 2005;48:2076–9. doi:10.1007/s10350-005-0146-1.

    Article  CAS  PubMed  Google Scholar 

  18. Matthiessen P, Hallböök O, Rutegård J, Simert G, Sjödahl R. Defunctioning stoma reduces symptomatic anastomotic leakage after low anterior resection of the rectum for cancer: a randomized multicenter trial. Ann Surg. 2008;247:719–20. doi:10.1097/SLA.0b013e31816a74b5.

    Article  Google Scholar 

  19. Beck-Kaltenbach N, Voigt K, Rumstadt B. Renal impairment caused by temporary loop ileostomy. Int J Colorectal Dis. 2011;26:623–6. doi:10.1007/s00384-010-1086-3.

    Article  PubMed  Google Scholar 

  20. Kann BR. Early stomal complications. Clin Colon Rectal Surg. 2008;21:23–30. doi:10.1055/s-2008-1055318.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Robertson I, Leung E, Hughes D, et al. Prospective analysis of stoma-related complications. Colorectal Dis. 2005;7:279–85. doi:10.1111/j.1463-1318.2005.00785.x.

    Article  CAS  PubMed  Google Scholar 

  22. Chude GG, Rayate NV, Patris V, et al. Defunctioning loop ileostomy with low anterior resection for distal rectal cancer: should we make an ileostomy as a routine procedure? A prospective randomized study. Hepatogastroenterology. 2008;55:1562–7.

    CAS  PubMed  Google Scholar 

  23. Mark K, Uranitsch S, Pedross F, et al. Colon/rectum diverting ileostomy versus no diversion after low anterior resection for rectal cancer: a prospective, randomized, multicenter trial. Surgery. 2016;159:1129–39. doi:10.1016/j.surg.2015.11.006

    Article  Google Scholar 

  24. Seo S-I, Yu CS, Kim GS, et al. The role of diverting stoma after an ultra-low anterior resection for rectal cancer. Ann Coloproctol. 2013;29:66. doi:10.3393/ac.2013.29.2.66.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Hanna MH, Vinci A, Pigazzi A. Diverting ileostomy in colorectal surgery: when is it necessary? Langenbecks Arch Surg. 2015;400:145–52. doi:10.1007/s00423-015-1275-1.

    Article  PubMed  Google Scholar 

  26. Luglio G, Pendlimari R, Holubar SD, Cima RR, Nelson H. Loop ileostomy reversal after colon and rectal surgery: a single institutional 5-year experience in 944 patients. Arch Surg. 2011;146:1191–6. doi:10.1001/archsurg.2011.234.

    Article  PubMed  Google Scholar 

  27. Doud AN, Levine EA, Fino NF, Stewart JH, Shen P, Votanopoulos KI. Stoma creation and reversal after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2016;23:503–10. doi:10.1245/s10434-015-4674-1.

    Article  PubMed  Google Scholar 

  28. Sugarbaker PH. Avoiding diverting ileostomy in patients requiring complete pelvic peritonectomy. Ann Surg Oncol. 2015;23:1481–5. doi:10.1245/s10434-015-4961-x.

    Article  PubMed  Google Scholar 

  29. Shiomi A, Ito M, Maeda K, et al. Effects of a diverting stoma on symptomatic anastomotic leakage after low anterior resection for rectal cancer: a propensity score matching analysis of 1014 consecutive patients. ACS. 2015;220:186–94. doi:10.1016/j.jamcollsurg.2014.10.017.

    Google Scholar 

  30. Schnüriger B, Inaba K, Wu T, Eberle BM, Belzberg H, Demetriades D. Crystalloids after primary colon resection and anastomosis at initial trauma laparotomy: excessive volumes are associated with anastomotic leakage. J Trauma Injury Infect Crit Care. 2011;70:603–10. doi:10.1097/TA.0b013e3182092abb.

    Article  Google Scholar 

  31. Boesen AK, Maeda Y, Madsen MR. Perioperative fluid infusion and its influence on anastomotic leakage after rectal cancer surgery: implications for prevention strategies. Colorectal Dis. 2013:15:e522. doi:10.1111/codi.12321

    CAS  PubMed  Google Scholar 

  32. Waterland P, Goonetilleke K, Naumann DN, Sutcliff M, Soliman F. Defunctioning ileostomy reversal rates and reasons for delayed reversal: does delay impact on complications of ileostomy reversal? A study of 170 defunctioning ileostomies. J Clin Med Res. 2015;7:685–9. doi:10.14740/jocmr2150w.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Junginger T, Gönner U, Trinh TT, Lollert A, Oberholzer K, Berres M. Permanent stoma after low anterior resection for rectal cancer. Dis Colon Rectum. 2010;53:1632–9. doi:10.1007/DCR.0b013e3181ed0aae.

    Article  PubMed  Google Scholar 

  34. Çubukçu A, Alponat A, Gönüllü NN. Mitomycin-C prevents reformation of intra-abdominal adhesions after adhesiolysis. Surgery. 2002;131:81–4. doi:10.1067/msy.2002.118316.

    Article  PubMed  Google Scholar 

  35. Çubukçu A, Alponat A, Gönüllü NN, Özkan S, Erçin C. An experimental study evaluating the effect of mitomycin C on the prevention of postoperative intraabdominal adhesions. J Surg Res. 2001;96:163–6. doi:10.1006/jsre.2000.6059.

    Article  PubMed  Google Scholar 

  36. Liu Y, Li H, Shu X, Gray S, Prestwich G. Crosslinked hyaluronan hydrogels containing mitomycin C reduce postoperative abdominal adhesions. Fertil Steril. 2005;83:1275–83. doi:10.1016/j.fertnstert.2004.09.038.

    Article  CAS  PubMed  Google Scholar 

  37. Chung J. Mitomycin C for the prevention of adhesion formation after endoscopic sinus surgery: a randomized, controlled study. Otolaryngol Head Neck Surg. 2002;126:468–74. doi:10.1067/mhn.2002.124705.

    Article  PubMed  Google Scholar 

  38. Orhan A, Görmüş N, Toy H, Görmüş IS, Çağlayan O, Tanyeli Ö. Prevention of retrosternal pericardial adhesions after cardiac surgery with mitomycin C. Heart Lung Circulation. 2014;23:357–62. doi:10.1016/j.hlc.2013.10.080.

    Article  Google Scholar 

  39. Jacquet P, Sugarbaker PH. Abdominal adhesions causing intestinal obstruction following cytoreductive surgery and early postoperative intraperitoneal chemotherapy. Acta Chir Austriaca. 1995;27:92–5.

    Article  Google Scholar 

  40. Markman M, Cleary S, Howell SB. Complications of extensive adhesion formation after intraperitoneal chemotherapy. Surg Gynecol Obstet. 1986;162(5):445–8.

    CAS  PubMed  Google Scholar 

  41. Blouhos K, Pramateftakis M-G, Tsachalis T, et al. The integrity of colonic anastomoses following the intraperitoneal administration of oxaliplatin. Int J Colorectal Dis. 2010;25:835–41. doi:10.1007/s00384-010-0912-y.

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

There are no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alessio Pigazzi MD, PhD.

Additional information

The original version of this article was revised: Sarath Sujatha-Bhaskar’s family name was misspelled.

An erratum to this article is available at http://dx.doi.org/10.1245/s10434-017-5893-4.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Whealon, M.D., Gahagan, J.V., Sujatha-Bhaskar, S. et al. Is Fecal Diversion Needed in Pelvic Anastomoses During Hyperthermic Intraperitoneal Chemotherapy (HIPEC)?. Ann Surg Oncol 24, 2122–2128 (2017). https://doi.org/10.1245/s10434-017-5853-z

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-017-5853-z

Keywords

Navigation